Wells Fargo analyst Larry Biegelsen lowered the price target for Integra LifeSciences from $18 to $15 following the company's revised 2026 revenue and earnings forecasts. The downgrade comes after flooding in July disrupted operations at Integra's Cincinnati facility, leading to reduced revenue guidance of $1.634-$1.654 billion and adjusted earnings of $2.30-$2.40 per share. Despite this, Integra expects strong operating cash flow and plans to refinance $600 million in debt with a seven-year loan. The stock dropped 21.19% to $12.68 amid these updates.
Integra LifeSciences saw its stock drop 21.19% to $12.68 after a Wells Fargo price target cut to $15. For readers following the health sector, here is Pluang's market snapshot as of Oct 05, 2026 19:11 WIB: out of 100 priced US health stocks, 46 rose and 40 fell. Notable movers include Zimmer Biomet Holdings Inc (ZBH) at USD 89.44 with a +1.30% change and typical hold time on Pluang of 88 days, Revvity Inc (RVTY) at USD 153.50 with a +1.30% change and typical hold time of 12 days, and Novo Nordisk A/S (NVO) at USD 36.88 with a -1.18% change and typical hold time of 115 days.
SPX Technologies (NYSE: SPXC) recently traded near its 52-week low around $170, down about 1.6% from the previous close. Despite this, several analysts maintain positive outlooks with price targets ranging from $250 to $301, indicating potential upsi...
PBF Energy's shares have surged 173% over the past year, nearing record highs due to stronger refining margins and improved quarterly results. The company reduced its net term debt by over $1.4 billion in Q2 2026, refinanced notes, and maintained nea...
J D Wetherspoon reported an 8.6% increase in like-for-like sales in the first nine weeks of its new financial year, helped by favorable weather. However, profit before tax fell 28% to £58.60 million despite a 5.2% revenue rise to £2.24 billion, mainl...
Oppenheimer has maintained its Outperform rating on Enphase Energy but lowered the price target from $56 to $55. Enphase Energy, a company specializing in solar microinverters, home batteries, and energy management products, has seen its shares drop ...
UBS increased its price target for Ball Corp. from $65 to $66, citing steady demand for packaging products and growth in South America. The stock currently trades at $56.37, implying a potential 17.1% upside. Key factors supporting investor interest ...
